The COVID-19 pandemic has had a negative impact on colorectal cancer screening and treatment due to the suspension or delay of screening programs and a decrease in routine medical appointments. This can lead to a delay in its diagnosis and treatment, which can have a negative impact on patient survival.
It is certain that the COVID-19 pandemic has had a significant impact on medical care, including colorectal cancer screening and treatment. The suspension or delay of screening programs and a decrease in routine medical appointments have led to a delay in the diagnosis and treatment of colorectal cancer, which may have a negative impact on patient survival. In addition, colorectal cancer patients have had difficulty accessing treatment and follow-up due to limited travel and lack of resources.
It is important that health authorities redouble efforts in colorectal cancer screening to try to minimize the increase in cases and adopt new diagnostic techniques that are more effective than colonoscopy. In addition, the importance of not delaying routine medical appointments and early detection of colorectal cancer should be emphasized, as this can be crucial for patient survival.
Ultimately, although the COVID-19 pandemic has had a significant impact on medical care, we cannot forget the importance of early detection and treatment of colorectal cancer. We must work together to ensure that colorectal cancer patients receive the care and treatment they need, even during the pandemic.
